Sibylla Biotech Company
Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
Headquarters:
45.4756089
Industry:
Genetic and synthetic biology medicine
Super Industry:
Frontier Medicine & Bioengineering
Funding Stage:
Early Stage Venture
Funding Total Value:
23000000
Last Funding Total Usd:
22962731
Last Funding Total Currency:
EUR
Last Funding Total Value:
23000000
Phone Number:
+39 347 650 3353